230 related articles for article (PubMed ID: 33782837)
1. Performance of Area under the Concentration-Time Curve Estimations of Vancomycin with Limited Sampling by a Newly Developed Web Application.
Oda K; Hashiguchi Y; Kimura T; Tsuji Y; Shoji K; Takahashi Y; Matsumoto K; Kawamura H; Saito H; Takesue Y
Pharm Res; 2021 Apr; 38(4):637-646. PubMed ID: 33782837
[TBL] [Abstract][Full Text] [Related]
2. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
Pai MP; Neely M; Rodvold KA; Lodise TP
Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
[TBL] [Abstract][Full Text] [Related]
3. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
4. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data.
Fewel N
J Clin Pharm Ther; 2021 Oct; 46(5):1426-1432. PubMed ID: 34169543
[TBL] [Abstract][Full Text] [Related]
6. The Impact of AUC-Based Monitoring on Pharmacist-Directed Vancomycin Dose Adjustments in Complicated Methicillin-Resistant
Stoessel AM; Hale CM; Seabury RW; Miller CD; Steele JM
J Pharm Pract; 2019 Aug; 32(4):442-446. PubMed ID: 29554847
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the mathematical equation and trapezoidal approach for 24 h area under the plasma concentration-time curve calculation in patients who received intravenous vancomycin in an acute care setting.
Chanapiwat P; Paiboonvong T; Rattanaumpawan P; Montakantikul P
Pharmacol Res Perspect; 2023 Feb; 11(1):e01046. PubMed ID: 36588162
[TBL] [Abstract][Full Text] [Related]
8. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
Frymoyer A; Guglielmo BJ; Hersh AL
Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
[TBL] [Abstract][Full Text] [Related]
9. Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve-Guided Vancomycin Dosing: A Short Communication.
Horita Y; Asaoka M; Iida M; Kato H; Wachino C; Mitamura K; Ohashi K; Mimura Y; Hotta Y; Kataoka T; Nakamura A; Kimura K
Ther Drug Monit; 2023 Apr; 45(2):245-250. PubMed ID: 36006610
[TBL] [Abstract][Full Text] [Related]
10. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
[TBL] [Abstract][Full Text] [Related]
11. Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data.
Maung NH; Methaneethorn J; Wattanavijitkul T; Sriboonruang T
Eur J Hosp Pharm; 2022 Mar; 29(e1):e57-e62. PubMed ID: 34285111
[TBL] [Abstract][Full Text] [Related]
12. Dosing vancomycin in the super obese: less is more.
Crass RL; Dunn R; Hong J; Krop LC; Pai MP
J Antimicrob Chemother; 2018 Nov; 73(11):3081-3086. PubMed ID: 30203073
[TBL] [Abstract][Full Text] [Related]
13. Prediction Accuracy of Area under the Concentration-Time Curve of Vancomycin by Bayesian Approach Using Creatinine-Based Equations of Estimated Kidney Function in Bedridden Elderly Japanese Patients.
Sonoda A; Iwashita Y; Takada Y; Hamazono R; Ishida K; Imamura H
Biol Pharm Bull; 2022 Jun; 45(6):763-769. PubMed ID: 35370223
[TBL] [Abstract][Full Text] [Related]
14. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations.
Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S
Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207
[TBL] [Abstract][Full Text] [Related]
15. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
[TBL] [Abstract][Full Text] [Related]
16. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
Tsutsuura M; Moriyama H; Kojima N; Mizukami Y; Tashiro S; Osa S; Enoki Y; Taguchi K; Oda K; Fujii S; Takahashi Y; Hamada Y; Kimura T; Takesue Y; Matsumoto K
BMC Infect Dis; 2021 Feb; 21(1):153. PubMed ID: 33549035
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant
Covvey JR; Erickson O; Fiumara D; Mazzei K; Moszczenski Z; Slipak K; Nemecek BD; Zimmerman DE; Guarascio AJ
Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
[No Abstract] [Full Text] [Related]
18. Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
Hsu AJ; Hamdy RF; Huang Y; Olson JA; Ghobrial S; Gerber JS; Hersh AL; Tamma PD
J Pediatric Infect Dis Soc; 2018 Dec; 7(4):338-341. PubMed ID: 28992126
[TBL] [Abstract][Full Text] [Related]
19. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
Oda K; Jono H; Nosaka K; Saito H
Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients.
Suchartlikitwong P; Anugulruengkitt S; Wacharachaisurapol N; Jantarabenjakul W; Sophonphan J; Theerawit T; Chatsuwan T; Wattanavijitkul T; Puthanakit T
J Clin Pharmacol; 2019 Dec; 59(12):1597-1605. PubMed ID: 31342543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
